Clinical trials
Terminated Recurrence trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Pfizer | 3 |
| AbbVie | 2 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Amgen | 1 |
| Eisai Limited | 1 |
| Gilead Sciences | 1 |
| Incyte Biosciences Japan GK | 1 |
| Janssen Pharmaceutical K.K. | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 19 |
| Multiple Myeloma | 6 |
| Neoplasms | 4 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma | 3 |
| Neoplasm Metastasis | 3 |
| Demyelinating Diseases | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Myelitis, Transverse | 2 |
| Neuromyelitis Optica | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.